XLON
BVC
Market cap87mUSD
Jul 09, Last price
15.00GBP
1D
2.74%
1Q
17.65%
Jan 2017
-19.46%
Name
Batm Advanced Communications Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BATM Advanced Communications Ltd., alongside its affiliated companies, specializes in the innovation, production, and commercialization of cutting-edge real-time technologies throughout Israel, the United States, and Europe. The enterprise conducts its operations through two distinct divisions: Networking and Cybersecurity, and Bio-Medical. The Networking and Cybersecurity division is responsible for the research, development, manufacturing, and market introduction of various data communication products. These offerings encompass technologies such as network function virtualization, edge computing, carrier ethernet, MPLS access solutions, advanced cyber network monitoring, and robust network encryption. Additionally, this segment delivers a range of software services, including user training, technical support, laboratory assistance, and ongoing maintenance, as well as undertaking construction contracts. Conversely, the Bio-Medical division focuses on delivering molecular biology diagnostic tools and provides comprehensive solutions for managing and neutralizing hazardous pathogenic and medical waste generated in environments like laboratories, hospitals, pharmaceutical production facilities, and agricultural settings. This segment also performs diverse testing services and serves as a distributor for a wide array of diagnostic apparatus and medical consumables from various brands. Established in 1992, BATM Advanced Communications Ltd. maintains its principal corporate office in Hod Hasharon, Israel.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||